MACAO, Oct. 16, 2025 /PRNewswire/ — The St. Regis Bar Macao is pleased to present an exclusive collaboration with the Parisian alchemist – Guerlain, a legendary House of high perfumery and high cosmetics, from October 16 to November 15, 2025. The partnership will see the creation of a bespoke afternoon tea, inspired by the olfactory artistry of Guerlain’s L’Art & La Matière fragrance collection.

“We are delighted to partner with Guerlain, a house with which we share a profound commitment to heritage, legacy, and the art of crafting exceptional experiences,” said Stuart Wayne Douglas, General Manager of The St. Regis Macao. “We believe that the fusion of culinary and olfactory arts will create a deeply sensory encounter, offering our guests a truly distinctive and lasting memory as part of the St. Regis afternoon tea rituals.”

This culinary interpretation invites discerning guests to experience the nuances of high perfumery through a curated selection of sweet and savoury delicacies. Each creation is conceived to reflect the character of a signature scent, from the luminous freshness of Neroli Outrenoir to the warm, intricate notes of Spiritueuse Double Vanille. Each delicacy is a carefully composted arrangement, where a harmony of different tier notes unfold upon the palate, guiding the guest on a progressive culinary journey.

Complementing the gastronomic offering, Our Head Mixologist Kevin Lai has curated a series of cocktails that articulate the complex profiles of the fragrances, ensuring a harmonious pairing throughout the experience.

For a more immersive encounter, a series of exclusive Fragrance Masterclasses will be held on October 18, November 1 and November 15. These sessions, led by Guerlain’s Fragrance master, will include a 100^th year anniversary celebration of the iconic Shalimar and an interactive tasting that pairs the afternoon tea creations with their fragrance inspirations. Attendance at the masterclasses is by reservation only.

Collaboration Details:

• Afternoon Tea Period: October 16 – November 15, 2025
• Fragrance Masterclasses: October 18, November 1 and November 15, 2025
• Location: Second floor, The St. Regis Bar at The St. Regis Macao
• Reservations: Required for the Masterclasses.
• Website: www.thestregisbarmacao.com
• Telephone: +853 2882 8898

About Guerlain
Guerlain is the Parisian alchemist that pursues an infinite quest for wonder of senses and crafts artistic beauty from Nature, since 1828. As a House of High Perfumery and High Cosmetics, it elevated bespoke to the level of Art. This is what makes it exceptional. Guerlain has been moved by passion for five generations, carrying a heritage where art and nature inspire every creation. Explorer of cultures, we are guided by a unique vision of beauty that awakens the senses and elevated the spirit. From one generation to the next, passing down its secrets, in an endless quest for the world’s most precious treasures. In the Name of Beauty, Guerlain commits itself and acts to elevate Nature into Art and to transmit its wonders to future generations, with the Bee as sentinel. Hand in hand with its customers and partners who share the same vision, the House of Guerlain works to imagine together a more beautiful and responsible world.

About The St. Regis Macao
The St. Regis Macao is the most prestigious address on the Cotai Strip. The hotel offers 400 exquisitely styled and lavishly appointed guestrooms and features The Manor, where elevates Mediterranean dining in Macau with Executive Sous Chef Michele Dell‘ Aquila’s refined cuisine – artisanal seafood, grilled specialties, and crafted cocktails, as well as The St. Regis Bar, an inviting retreat showcasing the full St. Regis Bloody Mary World Collection, including The St. Regis Macao original recipe –Maria do Leste (Mary of the East). The Spa at The St. Regis Macao, on the 38th floor, is Macao’s highest spa, boasting sweeping views of the stunning Cotai Strip and offers a rare retreat, a sensorial escape honoring the art of decadence. For meetings and events, the regal, 628-square meter Astor Ballroom is perfect for gala celebrations, distinguished corporate events or momentous weddings. For more information, please visit: www.stregismacao.com or follow The St. Regis Macao on Facebook, Instagram and WeChat@stregismacao.

GIRONA, Spain, Oct. 16, 2025 /PRNewswire/ — Superteam Wheels, a leading Chinese carbon fiber bicycle wheelset manufacturer, today announced a three-year strategic partnership with GCN Spanish channel (GCN en Español). This collaboration follows the successful partnership with the GCN French Channel (GCN en Français) on April 1, 2025, marking another significant step in Superteam Wheels’ global market expansion.

Through this partnership, Superteam Wheels will leverage GCN en Español’s influence across major social media platforms—including Facebook, Twitter, Instagram, and YouTube—to launch a series of promotional campaigns and collaborative content projects. The two parties will jointly produce diverse original content, including product reviews, riding experience showcases, and technical explanations, offering professional insights and inspiring cycling enthusiasm among enthusiasts worldwide.

Chris Zeng, Overseas Manager from Superteam, stated, “GCN stands as one of the most influential media platforms in the global cycling industry, we are thrilled to partner with GCN en Español. This collaboration not only represents a major milestone in Superteam Wheels’ international strategy but will also leverage GCN’s creative expertise and broad community reach to help more riders gain a deeper understanding of our products and brand values.”

Dario Esposito, Business Director at Play Sports Network, said, “I am very delighted to hear that you are also pleased with the successful collaboration between Superteam Wheels and GCN en Francais. The GCN en Español is truly thriving right now. This channel is doing incredible numbers this summer. I would love to expand our partnership to other channels in 2026!“

About Superteam Wheels

Founded in 2015, Superteam Wheels specializes in the R&D and manufacturing of high-performance, cost-effective carbon fiber wheelsets for road bicycles. With superior product quality, continuous innovation, and deep manufacturing expertise, the company has earned the trust of cyclists worldwide. Committed to advancing the cycling industry, Superteam Wheels continues to develop lighter, stronger, and more reliable carbon fiber technologies to deliver an exceptional riding experience for global users.

For more information, please visit: https://superteamwheels.com/

SYDNEY, Oct. 16, 2025 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supply Agreement for copper-67 with Nusano, Inc. (“Nusano”).

Nusano’s 190,000 square foot state-of-the-art facility in West Valley City, Utah is expected to begin operations in late 2025 with copper-67 isotope supply planned to commence in mid-2026. The proprietary accelerator-based technologies employed by Nusano are particularly well suited for high-volume mass production of copper-67. Nusano is uniquely positioned to regularly supply this therapeutic isotope for both Clarity’s clinical trials and commercial use based on the ease of production and readily available target material. Importantly, Nusano is setting up its own enriched stable isotope production for copper-67 starting materials in the near future, further reducing supply chain risks while allowing for a fully integrated production process in the United States.

The copper-67 supply from Nusano further expands Clarity’s growing network of US-based suppliers, including NorthStar Medical Radioisotopes, LLC (“NorthStar”) and Idaho State University Idaho Accelerator Center (IAC).

Dr Alan Taylor, Executive Chairperson of Clarity Pharmaceuticals, commented: “We are excited to continue growing our supply network for copper-67 in preparation for a registrational Phase III clinical trial with ⁶⁷Cu-SAR-bisPSMA, our lead product aimed at improving the treatment paradigm for men suffering with prostate cancer. With outstanding preliminary clinical trial data generated to date from our Phase I/IIa SECuRE trial and a Fast Track Designation in the US for this optimised product, we look forward to progressing our theranostic program, pending final study findings.

“Building reliable, abundant, sustainable and cost-effective supply goes hand-in-hand with our clinical development to allow us to swiftly scale manufacturing when needed. We have seen in the past the challenges associated with growing isotope supply with lutetium-177, which relies heavily on an ageing fleet of nuclear reactors, ultimately affecting care for oncology patients waiting for their treatments. We believe, the shift away from limited nuclear reactor-based supply to more easily scalable accelerator-based methods is a prerequisite for radiopharmaceuticals to grow sustainably into the large oncology sector. By employing copper-67, we can avoid many of the drawbacks of other therapeutic isotopes. Its production requires only electricity and readily available starting materials. With Nusano’s alternative production methods, we are further differentiating our supply and look forward to having numerous pathways to producing large quantities of copper-67.”

Nusano’s Chief Executive Officer, Chris Lowe, commented, “Nusano is commercialising a breakthrough radioisotope production platform in 2025 capable of producing more than 25 radioisotopes for life science applications. We are excited to deepen our relationship with Clarity through the signing of this Supply Agreement for copper-67 to enable their clinical and commercial efforts with a dependable supply of radioisotopes from our world-class production facility in Utah.

“Clarity is in a unique position with their copper-67 program, being the only radiopharmaceutical company with ongoing clinical trials utilising this important isotope, and we look forward to working together as they continue to progress their program toward registrational trials and commercialisation.”

Additional Disclosure

The Supply Agreement is effective as of 16 October 2025 and is for an initial period of 3 years with automatic renewal for successive 2-year periods. Cancellation provisions are aligned with industry standard rates.

Disclaimer

⁶⁷Cu-SAR-bisPSMA is an unregistered product. The safety and efficacy of ⁶⁷Cu-SAR-bisPSMA have not been assessed by health authorities such as the US Food and Drug Administration (FDA) or the Therapeutic Goods Administration (TGA). There is no guarantee that this product will become commercially available.

About Nusano

Nusano is a privately held physics company working to stabilize supply chains, advance American national security by reducing dependency on foreign supply, and enable once-in-a-generation innovations in fields ranging from healthcare to nuclear energy. The company is commercializing platform technologies for radioisotope production, stable isotope enrichment, and advanced separation techniques. Together, these proprietary systems and methods are poised to supply the fight against cancer, fuel the nuclear renaissance, and deliver critical minerals for the modern world. For more, visit nusano.com.

About Clarity Pharmaceuticals

Clarity is a clinical stage radiopharmaceutical company focused on the treatment of serious diseases. The Company is a leader in innovative radiopharmaceuticals, developing Targeted Copper Theranostics based on its SAR Technology Platform for the treatment of cancers.
www.claritypharmaceuticals.com

For more information, please contact:                               

This announcement has been authorised for release by the Executive Chairperson.

IRVINE, Calif., Oct. 16, 2025 /PRNewswire/ — EcoFlow, a leading portable power and renewable energy solutions company, today announced that its flagship OCEAN Pro residential energy storage system has been named to TIME’s list of the Best Inventions of 2025 in the Green Energy category, which highlights 300 groundbreaking innovations changing the way we live.

Each year, TIME’s editors and correspondents around the world nominate and evaluate products across emerging fields such as energy, health care and AI. The final list recognizes innovations based on originality, efficacy, ambition and impact.

EcoFlow OCEAN Pro stands out with its smart, all-in-one residential energy storage design, enabling homeowners to store and manage clean power with unmatched efficiency. With industry-leading capacity, safety and reliability, coupled with AI-powered energy management, OCEAN Pro delivers more than just backup power: it stabilizes the grid and meets AI-driven energy demands, advancing a smarter and more sustainable energy future. Beyond its features, OCEAN Pro is also designed for installer efficiency, simplifying setup and deployment for professional integrators.

“We’re honored that TIME has recognized OCEAN Pro as one of this year’s Best Inventions,” said, Jenny Zhang, President of the North America Residential Energy Business at EcoFlow. “This award affirms our commitment to bringing powerful solutions like OCEAN Pro to the world and giving families a smarter, stronger, and more reliable energy system built for the challenges they face today.”

EcoFlow OCEAN Pro’s recognition follows EcoFlow’s 2023 TIME Best Inventions award for the GLACIER portable fridge and 2021 award for the DELTA Pro portable power station, marking the company’s continued leadership in developing products that redefine how people generate, store and use energy.

Earlier this year, EcoFlow was also recognized on the TIME’s’ list of the World’s Top GreenTech Companies 2025, ranking among the top 250 companies globally. This honor highlights EcoFlow’s continued leadership in clean energy innovation and sustainability.

See the full list of TIME’s Best Inventions of 2025 here: time.com/collections/best-inventions-2025. For more detailed information, please visit EcoFlow US or EcoFlow Canada.

About EcoFlow

EcoFlow is a leading provider of eco-friendly energy solutions, commiitted to powering a new world.

Since its founding in 2017, EcoFlow has aimed to be the FIRST irpower solutions – Flexible, Innovative, Reliable, Simple, and Thorough-for individuals andfamilies, whether at home, outdoors or on the go. With a smart manufacturing center in China, and headquarters in the USA, Germany an Japan, EcoFlow has empowered over 5 million users in 140 rmarkets worldwide. For more information visit https://www.ecoflow.com/us.

LYNNWOOD, Wash., Oct. 16, 2025 /PRNewswire/ — Volpara Health has qualified for the American College of Radiology® (ACR®) Learning Network Vendor Partner designation. Volpara Health partnered with one of the latest graduates of the ACR ImPower Program Mammography Positioning Improvement Collaborative to identify opportunities to improve breast cancer detection through optimized mammography positioning.

Poor mammogram quality contributes to undetected breast cancer, with suboptimal positioning as the primary factor leading to technically inadequate exams. In most health systems, only 40–50% of mammograms meet ACR positioning criteria. Collaborative healthcare providers supported by Volpara Analytics have demonstrated measurable improvements—some effectively doubling performance and exceeding SMART goals.

A Unified Process for Lasting Improvement

The ImPower framework guides teams through systematic root-cause analysis, team alignment, and improvement cycles, while Volpara Analytics supplies the precise, data-driven insights needed to track positioning, compression, and overall image quality. Together, these elements create a feedback loop that not only identifies opportunities for improvement but also validates progress in real time.

“Having a structured improvement program like ImPower gives us the framework to align our technology rollout with a strong quality initiative,” said Morgan Myers, Advanced Application Specialist at Volpara Health, who has supported ImPower program participants. “With Volpara Analytics providing objective feedback, technologists have the confidence to test solutions, see immediate results, and sustain the improvements. The result is not just improved image quality but also greater staff engagement.”

Engaged Teams and Measurable Results

The shared language developed through ImPower, reinforced by objective Volpara data, allows clinical teams to align on what constitutes quality images and sustain higher performance standards.

“Enhancing and standardizing image quality within clinical workflows through technology requires strong collaboration between healthcare providers and software developers,” added Judy Burleson, ACR Vice President of Quality Management Programs. “The progress we’ve made was possible thanks to ImPower’s comprehensive education and support, along with Volpara’s responsiveness and commitment to evolving their product.”

Commitment to Quality Nationwide

“This collaboration is an important milestone in our shared work to improve mammography quality nationwide,” said Kris Bravo, Vice President of Customer Success at Volpara Health. “We’re proud to partner with the ACR to advance radiology performance through shared learning and measurable results. Supporting our customers in achieving and sustaining quality gains is central to our mission.”

Volpara’s engagement with the ACR builds on the success of several Volpara-supported sites that have participated in the ACR Mammography Positioning Improvement Collaborative. These sites have demonstrated how the dual force of structured methodology and objective analytics can accelerate and sustain quality improvement long after the program concludes.

“We’re more than a software provider,” said Bravo. “Our role is to be a trusted partner in quality improvement, providing customers with the tools, insights, and collaboration they need to deliver the best possible outcomes for their patients.”

Volpara remains committed to deepening its collaboration with the ACR Learning Network by actively pursuing further applications of AI to support consistent, high-quality breast imaging across diverse clinical settings.

Learn more about Volpara Analytics and its role in advancing breast imaging quality at www.volparahealth.com or by visiting us at RSNA 2025, booth #4100 in South Hall.

About Volpara Health

Volpara Health is on a mission to save families from cancer with AI-powered software that helps healthcare providers better understand cancer risk, guide personalized care decisions, and recommend additional imaging and interventions. Used in over 3,500 facilities by more than 9,500 technologists worldwide. Volpara’s software impacts nearly 18M patients, supports over 3.6M annual cancer risk assessments, and integrates seamlessly with electronic health records and imaging systems. Volpara helps radiologists quantify dense breast tissue with precision and technologists produce mammograms that have optimal positioning, compression, and dose. Volpara software also streamlines operations to ease compliance and accreditation. Volpara, a Lunit company, is headquartered in Wellington, New Zealand, and has an office in Seattle. Volpara is the trusted partner of leading healthcare institutions globally. For more information, visit www.volparahealth.com.

About the American College of Radiology

The American College of Radiology (ACR), founded in 1924, is a 42,000-member medical association that advances patient care, medical practice and collaborative results through advocacy, quality standards, research and education. www.acr.org 

NEW YORK, Oct. 16, 2025 /PRNewswire/ — Temple Digital Group announced that it successfully raised a $5M seed round to build a privacy focused trading platform for digital assets on the Canton Network.

Temple Digital Group

The round was led by Paper Ventures and included participation from YZi, CMT Digital, Sfermion, Halo Capital, Protagonist, 5N Canton, Eterna Capital, AMA, GSR, Selini, Presto and G20.

Temple leverages Canton‘s privacy-preserving architecture to deliver 24/7 markets with built-in compliance and connectivity to the broader digital-asset economy. The platform combines features of traditional electronic trading systems—such as automated order routing, all-to-all liquidity, and post-trade reporting—with blockchain innovations such as instant settlement, tokenization, and non-custodial wallets.

With the new funding, Temple plans to expand its product lines to support additional assets, financial instruments, and integrations across blockchain networks.

The Canton Network, whose development group, Digital Asset, recently raised 135M,has built a new technical stack to update the international financial system in collaboration with the world‘s largest institutions. Canton Network is already conducting trillions in monthly volume from products launched by major partners such as Goldman Sachs, Broadridge, BNP Paribas, and more.

Designed to meet institutional standards for privacy and compliance, Canton provides additional privacy and compliance features for capital markets —offering capabilities that networks like Ethereum and Solana cannot natively support.

The company‘s leadership team—Evan Varsamis (CEO) and Dan Simerman (CSO)—bring deep experience in digital assets, trading systems, and decentralized networks. The duo see Canton as ‘An Open Institutional Network‘ where anyone can access and build technology for the new financial system.

“We see an incredible opportunity to develop new financial primitives with and for large institutions ready to participate in digital asset markets” said Evan Varasmis, CEO and co-founder of Temple. “We want Temple to be a core trading engine for use cases that have traditionally been inaccessible on decentralized networks.”

About Temple Digital Group

Temple Digital Group is an infrastructure development company building a privacy focused technical stack to trade capital markets on the Canton Network.

Media Contact

Dan Simerman 
Dan@templedigitalgroup.com
templedigitalgroup.com
(201) 540-9430

ST. PETERSBURG, Fla. and TOULOUSE, France, Oct. 16, 2025 /PRNewswire/ — Acron Aviation, a global leader in aerospace safety systems, and Airbus, have announced a collaboration to deliver an upgrade solution for Airbus’ operators worldwide.

L to R: Loic Dunand, Head of Avionics and Airframe Upgrades Programme at Airbus, Jean-Michel Clairis-Gauthier, VP OEM Business Development and Sales at Acron Aviation, and Jean-Phillippe Labbay, Head of Systems Upgrade and FHS Procurement at Airbus.

Certified, Compliant, and Configurable

Acron Aviation’s 25-hour Cockpit Voice Recorder (CVR), marketed as SRVIVR25, is Airbus’ chosen solution for 25-hour CVR with recording capability. SRVIVR25, the only 25-hour CVR approved and qualified by Airbus thus far, is fully compliant with the Federal Aviation Administration (FAA) Reauthorization act and European Union Aviation Safety Agency (EASA’s) CVR regulations.

Through this Acron Aviation-Airbus collaboration, airlines can ensure regulatory compliance with minimal operational disruption. The SRVIVR25, designed for easy integration, enables fit-form-function replacements for legacy 2-hour CVRs, no matter the manufacturer, simplifying installation and minimizing aircraft downtime.

Integration, Supply and Standardization

The installation and the supply of the SRVIVR25 is offered and managed through an Airbus service bulletin. This ensures a robust integration with existing audio panels, cockpit area microphones, and datalink recording systems.

Operators will benefit from cost and operational advantages, including standardized part numbers across new production and upgrade installations, enabling common spares, simplified maintenance, and compatibility with existing ground support equipment (GSE) for fast, secure data access.

Future Ready

Built on over 60 years of Acron Aviation’s safety innovation, the SRVIVR25 is engineered for high capacity and aligned with upcoming ED-112B audio standards. Its advanced diagnostics and proven manufacturability ensure high-quality, consistent performance across all mission profiles.

Alan Crawford, Chief Executive Officer, Acron Aviation said: “This collaboration with Airbus ensures operators have access to our pioneering SRVIVR25 CVR, a product that sets industry standards and is fully certified to meet the evolving regulatory landscape.” Crawford continued, “SRVIVR25 includes versions with integrated Recorder Independent Power Supply (RIPS), significantly reducing wiring, space, and weight requirements while streamlining upgrades across diverse fleets, so airlines are not only meeting compliance standards, but they are also future proofing their fleets.”

NOTES TO EDITORS

About Acron Aviation

Acron Aviation is strategically aligned to deliver world-leading commercial aviation solutions designed to serve aircraft operators and airframe manufacturers across the globe. Our expertise extends to multiple facets of commercial aviation from OEM certified avionics to state-of-the-art simulation devices, best-in-class pilot training and market-leading flight data analytics. With a global footprint, we are uniquely positioned to deliver comprehensive, cutting-edge solutions that enhance our customers’ operations and further our mission of innovating to create safer skies. For more information visit acronaviation.com.